HEALTHIT.COM
Research
RESEARCH PREVIEW · evidence cutoff 2026-08-27
Menu
Recorded 2026-08-22Geisinger case: 70% faster prior auth TATRecorded 2026-08-22Infinitus SOC 2 Type II complianceRecorded 2026-08-22AKASA HITRUST/SOC 2 and 100% pre-bill reviewRecorded 2026-08-22Infinitus 2025 recap: 1.17M patients automatedRecorded 2026-08-22HIPAA/SOC 2 Type II; recordings deletedRecorded 2026-08-19Luma-PCC partnership to bring AI-enabled communications to 300+ pediatric practicesRecorded 2026-08-15Glass ranks top-tier on ARISE NOHARM clinical safety benchmarkRecorded 2026-08-15ISO 27001, HIPAA, 7+ FDA 510(k)s documentedRecorded 2026-08-15UpToDate integrated into Epic EHR/MyChart and ambient AI workflowsRecorded 2026-08-06UpToDate Expert AI adopted by ~2,500 U.S. hospitals and health systemsRecorded 2026-07-292.7M weekly interactions; US CAB launchRecorded 2026-07-23Anterior-Stellarus partnershipRecorded 2026-07-23Strategic partnership with Stellarus to enable real-time AI-driven prior authorization for health plansRecorded 2026-07-22Waystar Q2 2026 beat; AI anomaly detection tractionRecorded 2026-07-21Patient Pipeline: AI-powered new patient acquisition from ad spend to booked careRecorded 2026-07-21Luma launches AI Patient Pipeline for new patient acquisitionRecorded 2026-07-07SMART on FHIR + Epic Toolbox integrationRecorded 2026-06-30Nature Health SAFEMOM study shows Ada improves health-seeking behavior on MomConnectRecorded 2026-06-26Modality Partnership (NHS) rolls out Heidi across 53 sites in the UK's largest clinical deployment of ambient AIRecorded 2026-06-26NHS Modality Partnership rolloutRecorded 2026-06-24Roche acquires PathAI for ~$1B to bolster AI-based diagnostic algorithmsRecorded 2026-06-24Assort Health raises $120M Series C at $1.2B valuationRecorded 2026-06-15Thoreau Group signs $12B agreement to take control of Ensemble HealthRecorded 2026-06-11Med-Metrix closes back-to-back acquisitions of Vitalware and CanAide

Research preview · Vendor evidence as of 2026-08-27. Labels describe that snapshot, not a live assessment. Coverage & limitations

Workflow · Patient Access & Contact Center AI

Evidence readiness landscape

Documentary evidence, scenario match, and comparability are separate judgments.

0 of 6 products currently pass the documentary gate. 0 are scenario-comparable. Ranking stays closed until at least two products are comparable in the same scenario.

No ranking available yet — here is what would change that

  • Artera AI Platform needs: deployment traction, economic value, evidence strength, independent source present, interoperability and fresher evidence (currently historical). View its record →
  • Assort Health AI Agents Platform (Concierge, Activate, Orchestrate, Empower) needs: deployment traction, economic value, independent source present, interoperability and independent-source confirmation. View its record →
  • Klara Practice & Patient Collaboration Platform needs: deployment traction, economic value, evidence strength, independent source present, interoperability and fresher evidence (currently historical). View its record →
ProductDecision statusEvidence readinessCritical unknownLast verified
Artera AI Platform○ Historical · Research only499d median · 0/3 confirmedscaled production deployment · documented economic outcomes
Assort Health AI Agents Platform (Concierge, Activate, Orchestrate, Empower)Research only · Not yet comparable in this scenario64d median · 1/1 confirmedscaled production deployment · documented economic outcomes2026-08-27
Klara Practice & Patient Collaboration Platform○ Historical · Research only1930d median · 0/4 confirmedscaled production deployment · documented economic outcomes
Luma Health Operational AI Platform○ Historical · Research only460d median · 1/4 confirmedscaled production deployment · documented economic outcomes2026-08-27
Notable Intelligent Automation○ Historical · Research only255d median · 0/1 confirmedscaled production deployment · documented economic outcomes
Phreesia Patient Intake & Access Platform (incl. VoiceAI)○ Historical · Research only324d median · 0/5 confirmedscaled production deployment · documented economic outcomes

The documentary gate requires Current/Aging freshness AND gate-confirmed coverage on all four decision-critical dimensions including an independent source class. Products failing any condition render research-only with their exact gaps. Composite scores appear only inside each product’s assurance record as a diagnostic — never here. Documentary pass is not scenario eligibility, comparability, or decision readiness.